Michael A. Metzger - Sep 27, 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
President and COO, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Sep 27, 2021
Transactions value $
-$300,885
Form type
4
Date filed
9/28/2021, 04:36 PM
Previous filing
Sep 22, 2021
Next filing
Oct 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $176K +24.4K +138.38% $7.20 42.1K Sep 27, 2021 Direct
transaction SNDX Common Stock Sale -$477K -24.4K -58.05% $19.51 17.7K Sep 27, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -24.4K -100% $0.00* 0 Sep 27, 2021 Common Stock 24.4K $7.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
F2 The sales price ranged from $19.02 to $19.96
F3 This option is fully vested.